Status:
RECRUITING
Ofloxacin Concentration-toxicity Relationship in the Elderly
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Ofloxacin
Bone and Joint Infection
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Ofloxacin is a gold standard antibiotic for the treatment of bone and joint infections due to sensible staphylococcus strains. However, in the elderly, inter-individual variability of the pharmacokine...
Eligibility Criteria
Inclusion
- Patients aged over 65 years hospitalized at the University Hospital of Amiens for an uncomplicated bone and joint infections
- Indication for oral switch to ofloxacin
Exclusion
- Patient refusing to participate in the study
- Patient under guardianship or curators or deprived of public rights
- Any liver or biliary injury
- Any contraindications to ofloxacin
Key Trial Info
Start Date :
June 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04496024
Start Date
June 2 2020
End Date
August 1 2026
Last Update
June 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480